Search page

A 12 months real-life prospective study of lung function in patients with severe eosinophilic asthma undergoing therapy with ics/laba, lama, and anti IL5/5R monoclonal antibody

A Novel Treatment for Drug-Induced Acute Interstitial Nephritis: Benralizumab

A Phase 3 Open-Label Trial-In-Progress Evaluating Garadacimab For Prophylactic Treatment Of Pediatric Patients (Aged 2–11 Years) With Hereditary Angioedema

A Semi-Quantitative Evaluation of Leniolisib Treatment Response Through a Physician Survey of Patients with Activated PI3Kδ Syndrome (APDS) Under an Early Access Programme (EAP)

A Study Conducted in the Environmental Exposure Chamber (EEC) to Assess Onset of Action of Combination of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Dymista) in the Treatment of Allergic Rhinitis Symptoms Compared to Placebo

A case of Pneumothorax as first manifestation of asthma

A case of life-threatening asthma triggered by mood disorder and sexual abuse

A cost effective, self-sustaining, and effective way of improving asthma understanding in undergraduate students

A mechanosensitive cytoskeleton protein talin2 involved in asthma pathogenesis

A possible integrated mind-body approach to CSU treatment

A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma

A retrospective analysis of patients with chronic spontaneous urticaria in treatment with Omalizumab conducted in Brescia

AI, Biomarkers, and Big Data – Is Precision Medicine the Future of Asthma Care?

AI-derived trajectories of wheezing and asthma in children: a systematic review

Abatacept (cytotoxic T lymphocyte antigen 4-fragment crystallizable) treatment suppressed disease activity in a mouse model of Eosinophilic CRS

Accuracy of changes in fractional exhaled nitric oxide for diagnosing occupational asthma

Adherence to Long-Term Prophylaxis for Hereditary Angioedema and the Impact on On-demand Treatment Claims in the US

Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation

Adherence to the Planetary Health Diet and Asthma Risk in Children: Evidence from a Birth Cohort

Adjuvant allergen fusion proteins for the treatment of allergies

Adrenaline treatment in food-induced anaphylaxis – data from the European Anaphylaxis Registry

Adrenaline-use during the acute treatment of anaphylaxis – data from the European Anaphylaxis Registry

Adult Gut Microbiota and Metabolomics in Different Phenotypes of Asthma

Advances in Chronic Urticaria treatment

Advances in LTP allergy: mechanisms, diagnosis, and treatment

Advancing Asthma Diagnosis: Integrating Exhaled Biomarkers and Deep Neural Networks (DNNs) in a POC Breath Test

Adverse reactions to biologicals in severe asthma

AhR ligands in the treatment of atopic dermatitis

Algorithm for preventative treatment of viral infections reverses the negative impact of atopic traits on day-care absenteeism of preschool children

Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma

Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19

Allergenicity and Immunogenicity of Polypeptide-Conjugated Hepatitis B Core Antigen Virus‐Like-Particle (HBcAg-VLP) Vaccine for Treatment of Shellfish Allergy

Allergic Asthma in Children: The Hidden Role of Cockroaches

Allergic asthma

Allergic asthma – a challenge no more

Allergic asthma in a sample of dairy farmers

Allergy asthma and a sport

An explainable machine learning approach on early predictors of persistent childhood asthma and allergic rhinitis

An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)

Analysis of clinical and anamnestic risk factors of bronchial asthma in children

Analysis of exacerbating factors of pediatric asthma before and after the COVID19 pandemic

Anaphylaxis during OIT and its impact on treatment adherence: a monocentric retrospective study

Anti IgE for the treatment of chronic urticarial

Anxiety Associated with On-Demand Treatment for Hereditary Angioedema Attacks

Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy

Application Study on the prevention and treatment of spleen aminopeptide oral solution on seasonal allergic rhinitis

Application of Smart Wearable Devices in Management of Asthma

Apply cluster analysis and machine learning to identify phenotypes of work-related asthma

Approaching CRSwNP and asthma with biologicals – RWE data

Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma

Assessing specific pro-catabolic mediators (SPMs) as Innovative Biomarkers in Allergen Immunotherapy: Monitoring Treatment Efficacy

Assessing the Impact of Dupilumab Treatment on Lung Function in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Assessment of the safety of allogenic natural killer cells in the treatment of metastatic colon cancer

Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children

Association between Asthma and Risk of Respiratory Syncytial Virus-Acute Respiratory Infection in Adults 50 Years or Older Before and After the Covid 19-Pandemic in a Midwest Region of the U.S

Association between changes in blood eosinophil levels and alterations in olfactory function in asthma

Association of Antenatal Corticosteroid Treatment with Risk of Allergic Diseases in Children

Association of PTGS2 rs689466 polymorphism with asthma susceptibility among asthmatic of West Bengal, India

Association between obesity and repeated epinephrine administration for treatment of anaphylaxis: a Taiwan tertiary hospital experience from 2001 to 2020

Association of anthropogenic heat with asthma and related symptoms among children in China: a novel index reflecting climate change

Asthma Comorbidities – do they add more cost, A 3-year follow-up study in Réunion Island

Asthma Digital Health Tools and Opportunities for ArtificiaI Intelligence – Based Risk Prediction

Asthma Right Care – the growth of the social movement to reduce reliance on episodic care and to increase long term safe and person-centred care

Asthma and ABPA: Similarities and Differences

Asthma and Climate Change: A Five Year Study of Camp Wheez

Asthma and comorbidities

Asthma and nutrition

Asthma beginnings: Unraveling the early triggers

Asthma endotypes in the era of data science boom!

Asthma exacerbations and death after recovery from COVID-19: A nationwide long-term follow-up study

Asthma exacerbations in the pediatric emergency area: evaluation and prospects for improvement of pre-hospital care

Asthma in Brazilian children and adolescents

Asthma in children: Personalization and innovation for the future

Asthma in the Intermediate/Intensive Care of a Central Hospital

Asthma inception and trajectory through lifecourse

Asthma increases short-time sickness absence and presenteeism in young adults

Asthma is associated with increased sickness absence among young adults

Asthma management in the digital age

Asthma monitoring in children 2024 – the pearls from the PearL Think Tank

Asthma phenotype markers did not affect allergen immunotherapy effectiveness

Asthma remission in EGPA patients: applicability and concordance of the main international guidelines

Asthma remission: what is it and how can it be achieved?

Asthma response in patients with allergic rhinoconjunctivitis to grass pollen using an environmental exposure chamber

AstraZeneca – Transforming severe asthma respiratory care: the clinical experience

At the core of allergy and asthma pathology: exploring the connection between airway epithelium and effector cells

Atipic aggressive systemic mastocytosis in treatment with Avapritinib: a case report

Autoantibodies to interferon-gamma: clinical features, treatment outcomes, and in-vitro monitoring of disease

Autoimmunity in allergic diseases: implications for treatment

Balancing HAE and pregnancy: treatment recommendations and approaches

Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry

Baseline disease burden in severe asthma patients treated with biologics, and eligible but not treated: Spanish patients in the ISAR Registry

Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease

Benefits and pitfalls of high dose ICS in asthma

Benefits of non-invasive methods in the diagnosis of occupational asthma: example of asthma due to ammonium persulphate in a hairdresser

Benralizumab effectiveness in severe eosinophilic asthma patients from Central Eastern Europe and Baltics: BREEZE study

Benralizumab reduces annual cumulative OCS dose while improving asthma control and quality of life in severe eosinophilic asthma: Real-World Evidence from the AURORA study

Berotralstat Use Reduced Number of HAE Attacks Requiring Treatment or Professional Care in Pediatric Patients: Interim Results from APeX-P

Best tools for allergy and asthma translational research

Beyond elimination: Total diet approach for prevention and treatment of allergic disease

Biological treatment in asthmatic diseases

Biologics and airway remodeling in asthma

Biologics have Solved the Problem of Type 2 Asthma

Biomarkers for Atopic Dermatitis: Towards Personalized Treatment

Biomarkers for asthma and allergic diseases

Biomarkers shaping severe asthma phenotypes

Brazilian Anaphylaxis Registry: Main triggers, clinical manifestations and treatment

Breast-feeding is inversely associated with asthma and IgE sensitisation up to young adulthood

Breathing Easier: Cutting-Edge Advances in Paediatric Asthma Management

Briquilimab, an Anti-Human CD117 Antibody, Effectively Treats Cockroach Allergen-Induced Asthma Model Elicited in Mice Expressing Chimeric Human/Mouse CD117

Bronchiolitis and future risks for childhood asthma

Burden and subtypes of early-life infections increase the risk of asthma and adverse lung function

Can Artificial Intelligence-Based Large Language Models Provide Accurate and Reliable Information to Asthma Patients? A Comparative Analysis with Expert Insights

Can Sensory Processing Disorder Be A Comorbidity Of Allergic Asthma In Children?

Can the natural progression from allergic rhinitis to asthma be changed ?

Case Report: Management of Severe Asthma and Multiple Food Allergies with Omalizumab. Outcomes Following an 18-Month Step-Down Therapy

Case report of an occupational disease in a veterinarian with allergic asthma

Causes of death in patients diagnosed with severe asthma in our area- 10 years observational study

Challenges for transitional care for adolescents and young adults with asthma – from the healthcare professionals’ perspectives

Challenges in the treatment of CRSwNP with biologics

Changes in small airway physiology measured by impulse oscillometry in subjects with allergic asthma following methacholine and inhaled allergen challenge

Changes in the attacks’s frequency during Lanadelumab treatment in patients with hereditary angioedema from Romania

Changes in the awareness on anaphylaxis and asthma exacerbation: Education for 119 emergency department paramedics in Korea

Characteristics of Patients with Uncontrolled Severe Asthma Undergoing Biological Therapy Based on Spirometric Response: Our Experience

Characteristics of Severe type 2 Asthma Patients in China: A Retrospective Observational Study

Characterization of patients with Eosinophilic Esophagitis and response to first-line treatment in a Portuguese Immunoallergology Department

Chemical product exposure in professional cleaners and its relationship with occupational asthma

Childhood asthma and allergy is related to accelerated epigenetic aging in the LISA birth cohort

Chronic spontaneous urticaria with wheals, angioedema, or both: Differences in clinical characteristics, biomarkers and treatment response

Chronic urticaria across the ages: clinical features, comorbidities, and treatment response

Classification, early determinants and long-term impact on asthma of the IgG responses to rhinovirus VP1 (RV-VP1): a longitudinal study in two birth cohorts

Clinical Characteristics and Predictors in Patients with Difficult-to-Treat Asthma

Clinical Characteristics and Treatment Response of Eosinophilic Esophagitis in Pediatric Patients: A Descriptive Study from a High-Complexity Colombian Institution

Clinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: Patients from Spain in the ISAR Registry

Clinical Characteristics, Diagnosis, And Treatment Outcomes In Chronic Cold Urticaria: Insights From A 15-Year Study

Clinical Effectiveness of Tezepelumab on Upper and Lower Airway Symptoms in Patients with Asthma and Co-morbid Nasal Polyposis

Clinical Remission in Asthma and its Correlation with Nasal Comorbidities

Clinical and Healthcare Resource Use in Patients with Asthma and Low-Eosinophil Counts

Clinical and Inflammatory Characteristics of Occupational Asthma Caused by Persulfate Salts in Hairdressers: A Multicenter Cohort Study

Clinical and Treatment Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps by Treating Physician Specialty: Results from an EU Chart Review Study

Clinical characteristics and unmet treatment need in patients with hereditary angioedema treated with long-term prophylaxis: A real-world survey

Clinical evaluation of an immunotherapy treatment with Vespa velutina venom in allergic patients. Results from a prospective multicenter Study: W-STING Study

Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study

Clinical impact of Immune mechanisms driving asthma

Clinical implications of biologic therapies in comorbid severe asthma and CRSwNP

Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science

Clinical profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)

Clinical trials on Asthma and Rhinitis

Closing Gaps in HAE Management: Addressing Delays in On-Demand Treatment

Comparative Gene Expression Analysis in Blood Samples and Nasal Polyps during Dupilumab Treatment for CRSwNP

Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor Antagonists Versus Inhaled Corticosteroids Among Asthma Patients

Comparison of the proteomic profile in tears between patients with severe atopic dermatitis and severe asthma treated with Dupilumab

Comprehensive Analysis Of Pediatric ICU Admissions For Severe Acute Asthma Over A Decade

Correct Inhaler Technique as a Key Element of Asthma Management: Post-Education Evaluation of Patients’ Knowledge

Correlation between Fractional exhaled nitric oxide and pulmonary function test in children with asthma

CosMx™ single cell spatial imaging identifies changes in spatial cell communication in chronic rhinosinusitis with nasal polyps following anti – IL-5 treatment

Cracking the code on asthma prevention

Cutaneous Manifestations in Inborn Errors of Immunity: A Retrospective Analysis of Prevalence, Phenotypes, and Treatment Outcomes

Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis

Decrease in Eosinophil-Derived-Neurotoxin upon mepolizumab is associated with asthma improvement

Decrease in New-Onset Asthma During the COVID-19 Pandemic

Decreased frequency and severity of oral immunotherapy induced gastrointestinal eosinophilic reactions following revisions in treatment protocol

Defining Asthma Remission: Challenges and Potentials

Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers

Demographic Features Of Allergic Rhinitis Patients and Effect of Nasal Corticosteroid Treatment

Descriptive Analysis of Health-Related Physical Activity Patterns Among Korean Adolescents Diagnosed with Asthma

Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience

Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre

Determinants of fractional exhaled nitric oxide (FeNO) among workers at risk of developing occupational asthma in high-risk occupational settings

Development of AsthmaSense: A Web-Based Predictive Tool for Childhood Asthma Risk Assessment

Diagnosing Asthma with an Exhaled Breath Test at the Point of Care (POC)

Diagnosis and Treatment of Allergies at ENT Department of General Hospital of Nafplio, Greece

Diagnosis and treatment of allergies to emerging and locally relevant insects

Diagnosis of allergic asthma

Diagnosis of exercise-induced asthma

Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma

Disease Burden of Severe Asthma Patients Treated with Medium and High Doses of ICS: A Regional Database Analysis from China

Dissecting the molecular mechanisms underlying TSLP-driven non-type 2 inflammatory responses in severe asthma

Distribution of Patients with Asthma According to the New Immune Response Classification

Does severe asthma exist in preschool children?

Donidalorsen for the treatment of hereditary angioedema: Results from a phase 3, randomised, placebo-controlled trial

Dose reduction of dupilumab at 24 months of treatment in patients with controlled atopic dermatitis

Dual role of MAPK13 in epithelial barrier integrity and mucus production in asthma

Dupilumab Improves Lung Function and Reduces Exacerbation Frequency and IgE Levels in Patients with Asthma and Allergic Bronchopulmonary Aspergillosis (Phase 2 LIBERTY ABPA AIRED Study)

Dupilumab Reduces FeNO levels and Exacerbations and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study

Dupilumab Reduces Seasonal Exacerbation Rates in Children With Type 2 Asthma With or Without Evidence of Allergy

Dupilumab Reduces Systemic Corticosteroids in Children With Uncontrolled Moderate-to-Severe Asthma Regardless of Exacerbation History

Dupilumab Treatment Reduces IgE Levels in Patients Aged 2 to 17 Years With Atopic Dermatitis, Asthma, and Eosinophilic Esophagitis

Dupilumab Treatment is Associated with Clinical Improvement and a Shift towards a health-associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis

Dupilumab as a New Therapeutical Approach in Patients with Severe Seasonal Asthma Caused by Olive Pollen Sensitization

Dupilumab as effective treatment for chronic pruritus: a case report

Dupilumab for Treatment of Eosinophilic Gastrointestinal Disease in children

Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Dupilumab treatment effectively reduces nasal type 2 cytokine production following acetylsalicylic acid provocation in N-ERD patients

Dupilumab treatment leads to clinically meaningful improvements in a range of symptoms and quality of life in patients with eosinophilic esophagitis: Post hoc analysis of LIBERTY EoE TREET

Dupilumab-Induced Diffuse Eosinophilic Drug Rash with Hypereosinophilia in a Patient with Idiopathic Pulmonary Fibrosis and Severe Asthma Exacerbation: A First Case Report

Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions

Dupilumab: Improved Asthma Control and Quality of Life in Pediatric Patients – A Real-World, Single-Center Study

EAACI & AAAAI Joint Symposium : The Microbiome: A target for treatment and/or prevention of allergic disease

EAACI & AAAAI Joint Symposium – Atopic Dermatitis 2025: Novel Pathophysiology & Treatment Insights

EAACI & JSA Joint Symposium : New Insights into the Mechanism and Treatment Strategies for Unified Airway Disease

EAACI & IPCRG Joint Symposium : Improving the Delivery of Person-centred asthma care in global primary care

EAACI nomenclature for allergy and asthma

Early Real-World Outcomes of Tezepelumab in Severe Asthma Patients Unresponsive to Prior Biologics

Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps

Early gut microbiota in association to IgE-mediated asthma in young adults

Effect of anti IL-5/IL-5Rα biological treatment on tissue eosinophil subpopulations in patients affected by Chronic Rhinosinusitis with Nasal Polyp

Effect of baseline long-acting muscarinic antagonist (LAMA) use on inhaled corticosteroid dose reduction in patients with severe eosinophilic asthma treated with benralizumab: SHAMAL post-hoc analysis

Effectiveness of Dupilumab in improving Quality of Life in patients with “steroid-resistant” asthma and severe atopic dermatitis

Effectiveness of Tezepelumab in uncontrolled severe asthma. ADVANCAT (Advancing severe asthma care with Tezepelumab in Catalonia)

Effects of Using Filters on indoor air quality for asthma patients under arid conditions of United Arab Emirates

Efficacy and Safety of 1-Year Dupilumab Treatment in Children Aged 6-11 years with Moderate-to-Severe Atopic Dermatitis in South Korea: Multicenter Prospective Observational Study

Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design

Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Efficacy of Dupilumab in patients over 50 years of age with severe asthma

Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps

Efficacy of Re-treatment with Omalizumab in Adults with Chronic Spontaneous Urticaria who Relapsed after Treatment Withdrawal

Efficacy of Rilzabrutinib on Asthma Control: Results From a Double-Blind Placebo-Controlled Phase 2 Study

Efficacy of Rilzabrutinib on Asthma Quality of Life: Results From a Double-Blind Placebo-Controlled Phase 2 Study

Efficacy of two years of treatment with anti-IL-5/R therapy for reduction in use of oral glucocorticoids in patients with eosinophilic granulomatosis with polyangiitis

Efforts to Eliminate Childhood Asthma Death in China

Emergency treatment of anaphylaxis

Emerging Biologic Use May Reduce the Need for Corticosteroid Treatment and Surgery for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in France, Germany, Italy, Spain and the UK

Emerging therapies and approaches for achieving remission in severe asthma

Empowering Patients: Innovations in Allergic Rhinoconjuntivitis treatment

Endotyping chronic rhinosinusitis for a better treatment approach

Environmental impact of asthma treatment: prioritizing patient outcomes and reducing environmental burden

EoE treatment

Eosinophil granule proteins as a biomarker for managing asthma

Eosinophilic diseases: from nasal polyposis, eosinophilic asthma to EGPA (Eosinophilic Vasculitis with PolyAngioitis), evaluation of possible biomarkers of disease evolution

Eosinophilic esophagitis in children and adolescents: clinical, endoscopic, histologic findings, and response to treatment with: fluticasone, budesonide, proton inhibitors and dupilumab

Epigenome-wide association study of asthma exacerbations in European populations

Evaluating the Impact of Leniolisib Treatment on Symptoms and Health-Related Quality of Life (HRQoL) in Activated PI3Kδ Syndrome (APDS)

Evaluation of patients’ expectation and benefits of sublingual Named-Patient Products in the treatment of allergic respiratory diseases: the French ERAPP prospective cohort study

Evaluation of remission of Severe Asthma treated with monoclonal antibodies according to different definitions: a single center cohort

Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease

Evaluation of the Pediatric Patients with Severe Eosinophilic Asthma Treated with Mepolizumab

Evaluation of the level of asthma control in the pulmonology-phtisiology department of the Ignace Deen University Hospital

Evaluation of the tolerability of the administration of subcutaneous immunotherapy in a cluster schedule, in patients with rhinoconjunctivitis and/or asthma with sensitization to Olea europaea with or without sensitization to grasses

Evolution of health-related quality of life and disease control during the first year of Lanadelumab treatment in Romanian patients with Hereditary Angioedema due to C1-inhibitor deficiency

Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP

Exercise recommendations and practical considerations for asthma management

Exosomal Signaling and Mitochondrial Transfer Reprograms T Helper Cell Function in Human Asthma

Exploring association between lung function, asthma and epigenetic predisposition to obesity

Exploring potential predictive factors for time to response to Omalizumab treatment in a Romanian subset of patients with Chronic Spontaneous Urticaria

Exploring stem cells for allergy and asthma treatment: Potential without certification

Exploring the Potential of Serum Periostin and YKL-40 as Airway Remodeling Markers for Airway Hyperresponsiveness in Pediatric Asthma

Exploring the relationship between 6 minutes walk test (6MWT) performance and lung function in Severe Asthma and CRSwNP

Features of Perioperative Hypersensitivity Reactions Manifestations in Children with Bronchial Asthma

Features of the course of the antenatal and neonatal period of children with bronchial asthma

Finding the right asthma patient for LAMA therapy

First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma

Flash talks on Asthma

Flash talks on Pediatric Asthma

Focus on exercise and asthma management

Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring

Frequency of Herpes Zoster in Asthma and Associated Factors

Frequency of SNPs associated with pharmacogenetic phenotypes in Asthma in two Colombian populations

Frequency of asthma exacerbations in Mexican patients with Vitamin D insufficiency/deficiency and dyslipidemia

From Symptoms to MBPT: A Machine Learning Approach to Asthma Diagnosis

From adults to children: Translating severe asthma research to pediatrics

From suspected poorly controlled asthma to allergic bronchopulmonary aspergillosis

Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation

Furan fatty acid metabolites in pregnant women and newborns are associated with risk of childhood asthma

GSK – Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP

Genetic Associations of TSLP SNPs with Asthma Susceptibility and Severity

Genetic associations with asthma in the kazakh population

Genetic polymorphisms associated with the development of asthma in the Kazakh population

Genome-wide association study identifies CACNA2D3 associated with asthma and atopic dermatitis multimorbidity in children

Global Initiative for Asthma (GINA) Guidelines

Grape polyphenols increase the concentration of BPI in asthma patients who have had SARS-CoV-2

Grape polyphenols reduce the concentration of LPS in patients with asthma

Greener practice and patients’ outcomes in asthma

Group A – Asthma

Gut Microbiota and Phenotypes of Childhood Asthma

Health-Related Quality of Life and Clinical Characteristics in People Living with Hereditary Angioedema Prescribed Long Term Prophylaxis Alone and On-Demand Treatment Alone

Healthcare Provider Burden associated with the treatment of attacks in patients with hereditary angioedema in Latin America: A Pilot Study

Hereditary Angioedema Attack Diary Determination of the Effect of Mobile Application on Patients’ Quality of Life and Treatment Compliance Level

Hereditary Angioedema in Bulgaria: an update on patient characteristics and treatment modalities

Home-based introduction of egg protein in paediatric IgE-mediated Egg allergy – a review of treatment strategy 2011-2021 at Midland Regional Hospital Portlaoise

Hot Topics in Pediatric Asthma

House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents

How Food Allergen Sensitization Influences Asthma in Children with Atopic Dermatitis

How to deal with insufficient response to biologic treatment in CRSwNP

How to manage asthma patients in the clinic

How to manage treatment of a red eye

Human milk oligosaccharides 3’SL and 6’SL suppress airway hyperreactivity, while only 3’SL also reduces airway inflammation in a murine allergic asthma model

Hypoallergenic and anti-remodeling effect of a hybrid protein in a murine model of chronic asthma induced by Dermatophagoides pteronyssinus

ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up

IL-13 and airway calibre codetermine exhaled nitric oxide levels in type-2 asthma patients

ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy

Identifying Key Outcomes in the Treatment of Activated PI3K Delta Syndrome: Results From a Modified Delphi Panel

IgE reactivity profile to respiratory and food allergen components among patients with allergic rhinitis with and without asthma

IgG autoantiboides in asthma

Immune Skewing in pediatric asthma – clinical consequences

Immuno-metabolic reprogramming of bronchial epithelium in asthma

Immunodeficiency spectrum in patients with severe asthma receiving biologicals

Immunological changes induced by a salsola kaly extract in patients with allergic rhinitis or rhinitis and asthma

Impact of Asthma on Hospitalization and Antibiotic Courses in Common Variable Immunodeficiency Respiratory Infections

Impact of Delayed Treatment of Hereditary Angioedema Attacks: Insights from Patient Surveys Across France, the United Kingdom, and the United States

Impact of Immunogenicity on Clinical Outcomes in Patients from a Severe Asthma Unit Treated with Mepolizumab

Impact of Switching from Omalizumab to Dupilumab in Severe Asthma Patients: A Retrospective Evaluation of Efficacy and Inflammatory Biomarkers

Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset

Impact of air pollutants, influenza infection on asthma exacerbation

Impact of asthma as a chronic disease on the quality of life of the patient and his family

Impact of asthma on severe food-induced allergic reactions: a systematic review and meta-analysis

Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study

Impact of mepolizumab on exacerbations and maintenance OCS use in patients with asthma and baseline blood eosinophil counts of ≥150–<300 cells/μL in the REALITI-A study: 2-year outcomes

Impact of molecular allergy tests on diagnosis and treatment of eosinophilic esophagitis

Impact of overweight and obesity on clinical remission and Response to Biologics in Severe Asthma Patients

Improvement in Lung Function with Rademikibart in Eosinophilic Driven, Type 2 Asthma

Improving severe asthma through psychological management of traumatic life events

Inborn errors and treatment modalities

Increase in airway resistance and respiratory bronchial reactivity is accompanied by cellular and antibody Type 2 immune response in a mouse model of asthma induced by Der p 23 allergen

Indirect case matched comparison of dupilumab versus benralizumab on mannitol airway hyperresponsiveness in type 2 high severe asthma

Individualized treatment strategy in our unit in patients with predominantly Api m 10 sensitization profile

Inequalities on environmental exposures and allergic diseases and asthma

Infective asthma exacerbations in severe asthmatic patients receiving biological drugs

Inflammatory and Oxidative Stress Markers in Serum, Urine and Exhaled Breath Condensate: Relationship between Asthma and Obesity in Children

Inflammatory cytokine-mediated airway remodeling in asthma

Inflammatory phenotypes of severe asthma from sputum and plasma proteomic profiles

Influence of selected cytokines and chemokines on the ventilation efficiency in spirometric examination, in patients with asthma post-COVID-19

Inhaled corticosteroid-related neuropsychiatric side effects in children with asthma

Initial Results from SPOTLIGHT, a Phase 1b/2a Dose Escalation Study of the anti-c-Kit Briquilimab Antibody in Adults with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite H1-Antihistamine Treatment

Innate Immune Memory and Metabolic Reprogramming in the Lower Airway Epithelium of Patients with Allergic Asthma

Innovating allergy and asthma education: building a resilient future for global health

Insights from Benralizumab Treatment

Insights from the BREATHE Study: Comorbidity Burden and Biomarker Trends in Severe Asthma Patients

Integrating Breathomics with CPET: A Breath-Taking Approach to Exercise-Induced Asthma Monitoring

Interindividual variability in serum concentration of montelukast and metabolites in asthma patients

Interleukin-17A gene polymorphism contribute to the elderly asthma susceptibility: evidences from a case-control study

International Eczema Council symposium : Safety of JAK inhibitors in the treatment of inflammatory skin diseases

Intracellular cell-mediated cell-to-cell communication exacerbates the pro-inflammatory progression of asthma

Investigating the Role of IL17 rs763780 Gene Polymorphism Associated with Asthma among Population of West Bengal, India

Investigating the Role of TBXA2R rs4523 Gene Polymorphism Associated with Asthma among Population of West Bengal, India

Investigation of Asthma Characteristics in Women with Generalized Periodontitis and Polycystic Ovary Syndrome

Investigation of the predictors of asthma phenotypes (atopic and non-atopic asthma) using machine learning and traditional statistical techniques

Involvement of Janus kinase (JAK)-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells (ILC2s) in asthma

Is Mediterranean Diet Best for Asthma Prevention?

Is milk oral immunotherapy using a home up-dosing protocol a viable and safe treatment for the older milk allergic child?

Is remission an adequate therapeutic goal for severe asthma

Is there a role for a social movement approach. Lessons from Asthma Right Care

JAK Inhibitors for Atopic Dermatitis: A New Frontier in Treatment

JAK inhibitor treatment for inborn errors of Inborn Errors of Immunity (IEI).

Janus kinase inhibitors treatment for solid organ transplant associated graft versus host disease

Key considerations in the management of asthma

Lessons from asthma questionnaires

Levels of total IgE vs. specific IgE during childhood for defining and predicting T2-high asthma

Lipid metabolism and allergic asthma severity

Long-Term Dupilumab Treatment is Not Associated With an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis in an Open-Label Extension Study

Long-Term Efficacy of Mepolizumab at 5 Years in Patients with Severe Asthma

Long-Term Prophylactic Treatment With Oral Deucrictibant Improves Disease Control and Health-Related Quality of Life in Participants With Hereditary Angioedema in the CHAPTER-1 Open-Label Extension Study

Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study

Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma

Long-term Qipian® administration prevents airway inflammation in ovalbumin-induced mouse asthma via restoring Th1/Th2 balance and modulating gut microbiota

Long-term dupilumab effect on lung function in subgroups of pediatric patients with uncontrolled asthma

Long-term outcome of work-related asthma

Long-term safety of donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 open-label extension OASISplus study

Low education level, occupational exposure and no medication use increase the risk of uncontrolled asthma in Chinese patients: findings from baseline data of a multi-centre, single-arm study (CARE FOR ALL)

Lung Function Improvement is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-to-Severe Type 2 Asthma: A Post Hoc Analysis of QUEST

Lung Function Responder Rates in the VOYAGE study in Children with Moderate-to-Severe Type 2 Asthma Receiving Dupilumab at Week 52

Lung function and exacerbations by different type 2 inflammation criteria in a general asthma population

MY006: A Trispecific Antibody Blocking Four Allergenic Epitopes For the Treatment of Peanut Allergy

MY006: anti-allergen multispecific antibody for the treatment of peanut allergy

MY010: An Anti-Allergen Multispecific for the Treatment of Multiple Tree Pollen Allergies

MY010: anti-allergen antibodies for the treatment of Fagales pollen allergy

Management Challenges in Pediatric Asthma with Long QT Syndrome

Management of allergic asthma

Maternal Diet Index and childhood asthma and food allergy – a replication study from Sweden

Maternal exercise during pregnancy is associated with reduced risk of asthma in the child: a prospective birth cohort study

Measurement of serum specific IgE to Ryegrass allergen component Lol p 5 in the TAISAR cohort predicts risk of Thunderstorm Asthma

Measuring adherence to inhaled asthma controller medication

Mechanisms and Predictors of Response or Failure to Biologic Therapies in Asthma and Allergy

Mechanisms and applications in allergy and asthma research

Mepolizumab Improves and Sustains Asthma Control and Lung Function in Patients with Severe Asthma, Independent of Baseline IgE and FeNO in the Real World: 2-Year Results from REALITI-A

Mepolizumab as game changer in a case of severe occupational asthma with rhinitis and contact dermatitis

Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the SYNAPSE study: Focus on global airway disease

Meta-analysis of primary endpoint of PQ Grass field studies with optimized dose and treatment regimen of PQ Grass

MicroRNA Signatures of Pediatric Obesity-Associated Asthma: Identifying Molecular Links Between Obesity and Asthma in Children

Mid-Term Impact of Non-Pharmaceutical Interventions on the Epidemiology of Hospitalizations for Severe Asthma Exacerbation in Children : A Time-Series Analysis

Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure

Model-based machine learning to understand progression of asthma through life-course

Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities

Modification of biologic treatment in Super-responders

Molecular Clustering Using microRNA Expression Profiles in Pediatric Asthma Reveals Differential Corticosteroid Responsiveness

Molecular allergen sensitizations drive phenotypes of severe asthma in children: evidence from a megacity cohort (SAMP)

Monitoring Patients with Severe Eosinophilic Asthma Receiving Benralizumab in Allergy Centers in Greece for 8-12 months – REALISM-A Study (gReek rEAl Life regIStry of benralizuMab among Allergists)

Monocyte chemotactic factors in the airways of patients with asthma after an allergen challenge

Multicohort Analysis Profiles the Blood-Based Transcriptome Features of Adult and Childhood Asthma

Multiplex molecular allergy profile of allergic rhinitis patients from an allergic and asthma center, Thailand

Murine IgG1 increased by subcutaneous immunotherapy suppressed development of allergic asthma

NERD treatment options: from past to future

Nasal obstruction in children: diagnosis and treatment

Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)

Natural history and treatment of food allergy

Nature’s Role in Healing: Harnessing Biodiversity to Combat Asthma and Allergies

Navigating the asthma maze in children: insights into phenotypes, innovative treatments, and preventive measures

Nebulized inhaled epinephrine versus epinephrine autoinjector for the treatment of food-induced anaphylaxis in young children – a randomized controlled clinical trial

New treatment options in childhood atopic dermatitis

Novel Pollen Aerosolization System for Studying Inflammation in Differentiated Airway Epithelia from Patients with Allergic Rhinitis and Asthma

Novel Treatment Approaches for Patients with SM and Mediator-Related Symptoms

Novel treatment approaches in AR: AIT, Biolgicis or the combination?

Novelties in asthma Biomarkers and immunomodulatory pathways

OAS3: ENT, asthma and respiratory allergy

Obesity Modified the Genetic Effect on Risk of Asthma: A Genome-wide Association Study of Adult Asthma

Occupational Asthma Due to Tenebrio Molitor in the Owner of a Mealworm Farm: A Case Report

Occupational asthma due to Chinese yeast, Yeast and Peptone

Occupational asthma in hairdressers due to hair dyes containing para-amino compounds

Omalizumab Combined Chinese Traditional Medicine in a Complicated Severe Asthma after Bronchial Thermoplasty

Omalizumab as preventive treatment in patients with primary mast cell activation syndromes

Opening and Introductions: Challenges with Delays in On-demand Treatment

Optimising asthma management in children

Optimising support for patients with asthma – a primary care model

Oral Sebetralstat for On-demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results

Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach

Outcome and complications of COVID-19 among children with asthma in South Korea: a national incident cohort study

OverSEA: European Delphi Consensus Study on Best Practices for patients with Severe Eosinophilic Asthma and comorbid CRSwNP

Overview of Asthma On-Treatment Clinical Remission Data

PDS9: Asthma

PTGDR2 Blood Expression as a Potential Biomarker for Predicting Super-Response to IL-5-Targeted Therapies in Severe Asthma

Parasitic Infection as a risk factor for Childhood Asthma in Upper Egypt

Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks

Patients With Moderate-to-Severe Asthma Treated With Dupilumab Are More Likely to Meet Clinical Remission Criteria: Results From the VESTIGE Trial

Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens

Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma Experience Early and Sustained Benefit with Depemokimab in the Randomised, Double-Blind, Parallel-Group, Replicate ANCHOR-1/2 Studies

Peak Flow Monitoring in Asthma Control

Pectin dietary supplementation as potential treatment of lipid transfer protein allergy

Pediatric problematic severe asthma

Perceived Impact and Awareness of Climate Change among Climate-Vulnerable Adults with Asthma

Perseverance in Asthma Education: Controlling Frequent Wheezing in a schoolgirl

Personalized application of Biologics in pediatric allergy and asthma

Phenotypes and inflammatory molecular endotypes of chronic rhinosinusitis and its implication for asthma

Polistes gallicus: an alternative treatment for European paper wasp venom allergic patients?

Polyphenol concentrate reduces CRP in asthma patients who have had COVID-19

Post-emergency asthma management

Potential of biologicals usage in moderate asthma

Practical Guide to Biomarker-Driven Pediatric Asthma Management

Precision treatment for allergic diseases

Predicting Asthma in Preschool Children: The Role of Eosinophil Blood Counts During Acute Wheezing Episodes

Predicting pediatric asthma and airway disease

Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score

Predicting treatment response to oral immunotherapy in peanut-allergic children using multi-omics risk scores

Predictive Value of Bronchodilator Reversibility and FeNO in Assessing Positive Outcomes of Bronchial Provocation Tests in Asthma Patients

Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients

Predictors of Asthma Development Following Rhinovirus Infection in Preschool Children

Predictors of Exacerbation-Prone Asthma in children: comorbidities and T2 Biomarkers with allergy sensitization

Predictors of Relapse After Omalizumab Withdrawal in Adults with CSU with complete response to treatment

Predictors of Treatment Response to Biological Therapy in Patients with Severe Asthma: Insights from Induced Sputum Analysis

Predictors of biological therapy in severe asthma patients. An ambispective study from the BIOBADALER consortium

Predominance of eosinophilic pathogenetic mechanisms in a severe allergic asthma patient on biologic therapy

Preimplantation genetic testing in hereditary angioedema: prevention outperforms treatment

Preliminary analysis of microbiome and metabolomics characteristics of upper respiratory tract in school-age children with bronchial asthma

Prevalence and causes of AR and asthma in Mongolia

Prevalence and impact of allergic comorbidities in patients with severe atopic dermatitis in treatment with Dupilumab

Prevalence of asthma as comorbidity in uncontrolled CRSwNP prior to endoscopic sinus surgery – a cross-sectional study

Prevalence of severe fatigue and its contributing factors in patients with severe asthma

Prevalence of the sensitivity to aeroallergens among patients with asthma and allergic rhinitis (AR), based on skin prick test (SPT) and its seasonal variation

Prevention of allergic asthma

Pro-inflammatory cytokines (IL-6 and TNF), influence of the JAK-STAT cascade and negative regulation of the Hyppo pathway in the severe asthma phenotype

Probiotics Supplementation on mitigating adverse effects of Phthalate-Induced Asthma

Profile of patients treated with the 300IR liquid sublingual immunotherapy for cat allergy and perception of treatment effect: Results from a French survey

Progression of Underlying Disease in Pediatric Severe Asthma

Progressive increase of the intervals between omalizumab administration in severe asthma

Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema

Proposal of an algorithm for asthma diagnosis using molecular biomarkers

Prospective association between ultra-processed food consumption in childhood and the development of asthma and atopy

Proteomic Modulation by Dupilumab in Severe Seasonal Asthma: Insights from a Short-Term Treatment Study in Ole e 7-Sensitized Patients

Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Psoriasis, allergic rhinitis, biological treatment and immunological therapy – a case report

RHINA : What can we learn from the asthma guidelines

RSV Infection: A Catalyst for Allergy and Asthma Development

Raising the Bar in Asthma Management: On-Treatment Clinical Remission

Review of the development and latest perspectives in 2024 on Allergic Rhinitis and its Impact on Asthma (ARIA)

Rationale and Design of the ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of Hereditary Angioedema (HAE)

Ravaging land, mind and lungs: asthma is associated with PTSD in individuals exposed warzones

Real-Life effectiveness of a Cohort of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Concomitant Moderate Persistent Asthma Treated with Dupilumab

Real-life data analysis of severe asthma patients undergoing biologic therapy: OCS consumption and respiratory function evaluation

Real-life efficacy of dupilumab in patients with asthma phenotype overlap- data from a tertiary pulmonary centre

Real-life experience after 6 months with Tezepelumab in specialized asthma units across northern Spain

Real-life experience and the safety of Immunobiologicals in the treatment of immunoallergic diseases

Real-life experience in eosinophilic granulomatosis with polyangiitis (EGPA) after 12 months with mepolizumab 300mg in specialized autoimmune and asthma units in an Universitary Hospital

Real-life experience with tezepelumab in severe allergic asthma

Real-world allergen immunotherapy effectiveness in allergic asthma

Real-world effectiveness of biologics in patients with severe asthma: analysis of the Korean Severe Asthma Registry (KoSAR)

Real-world efficacy of dupilumab as a second-line treatment in severe asthma- data from a tertiary pulmonary centre

Redefining STAT5B N642H Gain of function Mutation: Unique Phenotypic Features and First Successful Mepolizumab Treatment in a Pediatric Case

Reduced Allergic Asthma By Soy And Its Potential Mechanism Via Plasminogen Activator Inhibitor-1

Reduction in Annualized Exacerbations with Rademikibart in Eosinophilic Driven, Type 2 Asthma

Reduction in Oral Corticosteroid Burden in Patients With Moderate-to-Severe Asthma Initiating Dupilumab in the Real-World: The RAPID Registry

Regulatory Perspectives on Food Allergy Treatment and Research

Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria

Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients

Relevance of IL-17-associated immune pathways and CXCL10 expression in severe childhood asthma

Remibrutinib demonstrates sustained control of angioedema in patients with chronic spontaneous urticaria: 52-week treatment results from the phase 3 REMIX studies

Remission of asthma on biological therapy: one center experience

Respiratory muscle functions in asthma

Response to benralizumab in severe vernal keratoconjunctivitis after treatment failure with omalizumab

Retrospective analysis of quantitative CT characteristics of patients with severe asthma treated with biological agents: KoSAR registry

Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes

Risk stratification in primary care: how to use data to identify people in primary care at risk of harm due to under or over treatment and to prioritise their care

Risk stratification of drug allergy in children with immediate or delayed urticaria during antibiotic treatment

Role of The Gut Microbiome in Food Allergy: Potential For Prevention and Treatment

Role of biologics in the treatment for inborn errors of Inborn Errors of Immunity (IEI).

Role of nasal cytology in patients with bronchial asthma

Role of the single nucleotide variants of filaggrin, thymic stromal lymphopoietin and orsomucoid-1-like protein 3 in the development of atopic bronchial asthma phenotypes in children

Root and branch of childhood asthma management

SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria

SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis

SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma

Safety and Efficacy of Oral Deucrictibant for Treatment of Upper Airway and Laryngeal Hereditary Angioedema Attacks: Results from the RAPIDe-2 Extension Study

Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract

Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment

Sanofi : What’s New in CRSwNP? Real-Life Experiences and Current Treatment Goals

Sebetralstat as Oral On-demand Treatment for Hereditary Angioedema: Interim Analysis of Demographics and Attack Characteristics from the Open-label KONFIDENT-S Trial

Sebetralstat for Treatment of HAE Attacks in Patients Receiving Berotralstat, Lanadelumab, or C1 Inhibitor for Long-term Prophylaxis: Interim Analysis from KONFIDENT-S

Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?

Selection of Biologics for Severe Pediatric Asthma with Allergic Eosinophilic Phenotype

Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study

Serial fractional exhaled nitric oxide measurements at and off work: usefulness for diagnosis and tertiary prevention of occupational asthma

Serum Levels of Cytokine in Individuals with Severe Asthma with Obesity

Serum Periostin Level Predicted Length of Hospital Stay in Patients with Allergic Asthma

Severe Asthma and Depression: the Overlooked Burden

Severe Asthma and Obesity: A retrospective study

Severe Bronchial Asthma Phenotypes in a Referral Tertiary Center in Saudi Arabia

Severe Eosinophilic Asthma later recognized as EGPA treated with Benralizumab

Severe asthma associated with hereditary angioedema type 1 and other pathologies

Severe asthma in pediatrics and Dupilumab after failure with Omalizumab

Severe asthma or COPD with eosinophilic inflammation? – from uncertainty to remission under anti-IL-5R therapy

Sex differences in childhood asthma are driven by a T2-high phenotype and mediated through sex-hormone metabolites

Should dupilumab be the standard first treatment choice for severe atopic dermatitis?

Single cell sequencing to unravel asthma inflammation and remodeling

Skin as the target for allergy prevention and treatment

Stability of steroid-dependent severe asthma during 5-year follow-up

Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in mite allergic rhinitis patients with concomitant asthma

Stratification Value of Nasal Brushing Arachidonate 15-Lipoxygenase in Stapokibart (CM310) Treatment for Patients with Seasonal Allergic Rhinitis: Results from MERAK

Studies on the effects of various tobacco and nicotine use methods on the course and control of asthma

Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)

Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment

Study on the target level and influencing factors of dupilumab treatment in children with moderate to severe atopic dermatitis

Sub-study from the EAACI allergy educational needs in Primary Care Paediatricians to gauge association of GDP impact on differences of allergy diagnosis and treatment healthcare

Subcutaneous administration of a novel Virus-like Particle Vaccine for the Treatment of Peanut Allergy is safe and well tolerated

Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe in a pre/co-seasonal treatment regimen – a subgroup comparison

Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria

Successful Treatment of Post-Orgasmic Illness Syndrome with Omalizumab: A Report on Two Case

Successful treatment of lichen amyloidosis with dupilumab treatment: a case report

Successful treatment of upadacitinib in prurigo nodularis: a case report and review of the literature

Successfully managing severe asthma

Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in patients with bronchial asthma due to house dust mites or pollens

Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis

Systemic Treatment of Atopic Dermatitis in Pregnancy: The Physician’s Perspective

T2 inflammatory profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)

Targeted Metabolomic Profiling as a Tool for Assessing Response to Biologicals: a case of Dupilumab in Severe Allergic Asthma

Targeted therapies in pediatric severe asthma

Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice

Targeting TSLP in severe asthma

Tests to Diagnose Asthma

Tezepelumab reduces OCS use and improves sino-nasal symptoms in OCS-dependent patients with severe asthma and comorbid chronic rhinosinusitis (overall and with nasal polyps): results from the phase 3b WAYFINDER study

The Correlation Between Two Different Reversibility Criteria (GINA and ATS/ERS) Used in Asthma Diagnosis and the Relationship Between the Concordance of These Criteria and Phenotypic Features

The Effect of Japanese cedar pollen SLIT-tablets increases with years of treatment

The Effectiveness of Educational Interventions on Asthma Management in Children in Primary care settings: Systematic Review of Randomised Control Trials

The Eosinophil in Obstructive Airway Disease – Beyond Asthma

The Fundamental Role of Education in Achieving Control in a Child with Severe Uncontrolled Asthma

The HMOS 2’FL and 3FL prevent house dust mite induced proinflammatory cytokine release in vitro and decrease HDM-specific IgE in an allergic asthma murine model

The Heterogenicity of asthma

The Hidden Costs of Severe Asthma Treatment: Unveiling the Iatrogenic Burden

The Impact of Excess Weight and Obesity on Asthma Control in a Pediatric Population

The Impact of Obesity in Asthma and Small Airway Dysfunction: Prevalence, Clinical characteristics, and Predictors

The Respiratory Microbiota and Serum Metabolomics Characteristics in Different Endotypes of Asthma

The Role of Asthma and COVID-19 in Shaping the Severity of Pediatric Mycoplasma pneumoniae Infections: A Regional Perspective from the United States

The Role of Inflammatory Parameters in Predicting Allergy in Childhood Asthma

The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis with and without concomitant asthma – results from a global phase III clinical trial

The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study

The burden of allergic diseases and asthma – results from the HEAD registry

The diagnostic value of peripheral blood cell parameters, fractional exhaled nitric oxide, serum total IgE and lung function in eosinophilic asthma

The distinctive apoptosis pathways of late-phase allergic asthma in bronchial immune cells

The dynein adaptor Hook2 as microtubule-based transport and anchors for organelles is involved in asthma pathogenesis

The effect of early exposure to pet animals on allergy and asthma development

The effect of the community of residence on Wheeze/ asthma symptoms mediated through environmental risk factors and respiratory infection in children in southern Nigeria

The effectiveness and safety of Abrocitinib treatment for severe atopic dermatitis in the real-world data in Turkey

The efficacy in treatment of facial melasma combined with thulium 1927-nm fractional laser and topical H2R antagonist: a split-face, single-blind study

The epidemiological consequences of the war on asthma incidence

The evolution of HAE: Classification and goals of treatment

The formula of periocular eczema treatment gel prevents skin penetration of allergen extracts Phleum pratense and Dermatophagoides pteronyssinus

The gut fungome is associated with future risk of exacerbations, asthma control and quality of life in children with uncontrolled asthma: results from the PUFFIN study

The impact of Type 2- targeted biological therapies on persistent cough in adults with cough variant- or cough predominant asthma

The impact of asthma and mental health condition multimorbidity in national samples of Canadian children

The impact of limited access to On-Demand Treatment for Hereditary Angioedema on Quality of life: a comparison between two income settings

The impact of second-hand exposure to e-cigarette on asthma exacerbations in the pediatric population

The impact of treatment switching on healthcare resource utilization among patients with hereditary angioedema in the United States

The impact of wartime environmental change on the frequency of asthma diagnoses

The importance of breathing exercises in the rehabilitation of allergic asthma in children

The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment

The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood

The interaction of exposure to air pollutants and inflammatory markers on lung function and asthma symptoms in asthmatic patients

The m6A demethylase FTO mediates type 2 inflammation in asthma by regulating STAT6 mRNA stability

The modulation of ICAM-1 and ICAM-3 is mediated by alarmins in severe eosinophilic asthma

The new nomenclature for asthma and allergy

The parasympathetic nervous system plays a key role in control and stress in patients with asthma

The potential of anti-infectives and immunomodulators in pediatric asthma

The puzzling journey of asthma diagnosis – the IPCRG’s new educational approach.

The relevance of IL-5 biology in severe asthma

The role allergic sensitization in severe asthma

The role of T cell regulation and airway remodelling in asthma

The role of immunonutrition in the treatment of food allergies in children

The role of mucus in asthma and CRS severity

The significance of FeNO test in patients with different asthma endotypes

The successful resolve of nasal polyps in patient with dupilumab treatment

The triple type 2 signature is associated to asthma severity and comorbidity with CRS

The usefulness of the forced oscillation technique in the diagnosis of bronchial asthma in seniors

The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma

Therapeutic effectiveness and safety of cannabinoids in the treatment of atopic dermatitis: a systematic review

Tips and tricks for biological treatment of CRSwNP: setting the indication, choosing the right biological, managing side effects, switching, tapering

To study intra-breath variability in oscillometric parameters with level of asthma control among children from North India

Towards a Treat to Target approach in asthma: Asthma remission

Transforming severe asthma respiratory care: the clinical experience

Treatment Dilemmas in CARMIL2 Deficiency

Treatment Patterns in Patients Who Initiated Dupilumab in a Real-World Clinical Setting: The RAPID Registry

Treatment insights and potential differences

Treatment of Chronic Spontaneous Urticaria with Omalizumab Complicated by Onychodystrophy?

Treatment of Chronic Spontaneous Urticaria with Omalizumab during Pregnancy- Experience in a Portuguese Ucare

Treatment of HAE Attacks with Anticipated Future Oral On-demand Therapies as Reported by Patients

Treatment of atopic dermatitis patients with dupilumab restores functional responses of circulating skin-homing CD4+ T and B cells

Treatment of insulin allergy by intranasal Fc-fused preproinsulin

Treatment of refractory urticaria in children

Treatment of severe atopic dermatitis in pediatric patients with Dupilumab and effects of therapy on nasal and skin microbiota: preliminary experimental evidence

Treatment response in severe asthma: from rehabilitation to biologic

Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre

Trends in Sensitization to Pet Allergens and Correlation between Symptoms and Asthma in Allergic Rhinitis from 2017 to 2023 in China

Trends in the prevalence of asthma in Korean children: a population-based study from 1995 to 2022

Triggers and Mechanisms of Asthma Exacerbations: One Outcome, Many Paths?

Tumor necrosis factor-alpha in allergic inflammation in overweight children with asthma

Two cases of discrepancy between fractional exhaled nitric oxide and airway eosinophils in asthma

Type 2-high airway inflammation in childhood asthma distinguishes a more severe phenotype

Understanding treatment switching patterns and continuation rates for patients with hereditary angioedema receiving lanadelumab: analysis of real-world data

Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity

Unique role of Candida albicans sensitization in management of asthma patients living underground during military operations in Ukraine

Untargeted metabolomics reveals the metabolic profiles of children with allergic asthma in eastern and western China

Urban Forest Fungal Microbiome Diversity and Its Impact on Asthma and Allergic Inflammation

Urticaria in the context of treatment with trimethoprim/sulfamethoxazole due to trimethoprim sensitization

Use of Dupilumab as Adjuvant Treatment in Oral Food Desensitization: A Case Report

Use of biologics in severe uncontrolled asthma at National Institute of Pediatrics 2020-2023

Use of inactivated polybacterial mucosal vaccine (IPMV) as part of the treatment for the reduction of recurrent acute respiratory infections

Use of ketotifen as treatment for post viral infection cough in children

Validation of an Adapted Treatment Burden Questionnaire for Paediatric IgE-Mediated Milk and Egg Allergies: A Multicentre Study

Variables predicting clinical remission among adults with severe asthma treated with biologic agents

Viral infections and asthma exacerbations.

Vitamin D3 deficiency is more common in children with asthma than in children with other allergic diseases

Voice biomarkers: a new tool for asthma management

War related exposures and asthma development

Weighing the Pros and Cons of systemic steroids in CRS treatment

What are the predictors of asthma remission and what can we modify?

What is asthma remission and what can we learn from other autoimmune and inflammatory disease about remission?

What is the optimal time for diagnosis and treatment of peanut allergy in children?

What’s new in CRSwNP? Real-Life experiences and current treatment goals

Wheeze phenotypes in infants whose mothers have asthma

When and how it starts: unveiling the early development of asthma in preschool years

Which treatment to choose in AD patients with ocular disease?

Xiaoqinglong Decoction Combined with Yupingfeng Powder Alleviates Allergic Rhinitis Complicated with Asthma by Inhibiting B Lymphocyte Activation via JAK2/STAT1/MHC-II signaling pathway

Аnti-inflammatory effect of extracorporeal shock wave therapy as treatment for chronic calculous prostatitis

“Can Do, Do Do“ in patients with severe uncontrolled asthma referred for pulmonary rehabilitation in the alpine climate

Allergy and Asthma – Session 1: Diagnosing Asthma

Allergy and Asthma – Session 2: Precision medicine in pediatric asthma

Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Association of asthma severity with high sensitivity C-reactive protein (hsCRP) in the all-age asthma cohort ALLIANCE

Asthma Severity and Patient-Reported Outcomes in Patients With Asthma and Allergic Rhinitis Initiating Dupilumab in RAPID

Baseline Characteristics of Patients with Severe Asthma in Spain according to biological treatment use: BREATHE study

Baseline Predictors of Multicomponent Clinical Remission Following Dupilumab Treatment in Patients With Moderate-to-Severe Asthma

Basophil FceRI expression-A management tool in anti-IgE treatment of allergic asthma

Benralizumab as treatment in a patient with Near-Fatal Asthma exacerbation

Beyond the future – perspectives in the diagnosis and treatment of allergy and asthma

Biomarker-guided approach for treatment of preschool asthma

Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Characteristics of severe eosinophilic asthma in childhood-onset and adult-onset asthma in U-BIOPRED

Characterization of Patients With Asthma Initiating Dupilumab Treatment in a Real-World Setting: The RAPID Registry

Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment

Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children

Distribution of IL-1β Expression in Asthma Patients and Comparison of Therapeutic Efficacy of Different Administration Routes of IL-1β Neutralizing Antibody in a Mouse Model of Asthma

Dupilumab Reduces Exacerbations and Improves Asthma Control in Children With Moderate-to-Severe Type 2 Asthma, Regardless of Asthma Duration

Effectiveness of allergy immunotherapy on asthma medication use and asthma exacerbations: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study

Elevating patient treatment outcomes in Severe Asthma

Elevating patient treatment outcomes in Severe Asthma & comorbid CRSwNP

Environmental impact of asthma treatment

Eosinophilia over dupilumab treatment in asthma patients: a multicentric retrospective study

Evaluation of Asthma Course in Patients Hospitalized in Pediatric Intensive Care Unit Due to Severe Asthma Exacerbation

Evaluation of the concordance of definitions of Asthma Remission according to international guidelines in a cohort of patients treated with monoclonal antibodies for severe asthma

GSK – Elevating patient treatment outcomes in severe asthma and CRSwNP

Health Care Situation in the Treatment of Uncontrolled GINA 4/5 Asthma Patients in Germany: 2019 vs. 2022

Immune skewing and the impact on treatment response in adult asthma

Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study

KalVista Pharmaceuticals – Closing Gaps in HAE Management: Addressing Treatment Delays in On-Demand Treatment

Lichen Planus induced by treatment of severe eosinophilic asthma with biological therapy

Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis

Lymphocyte profile and asthma control during the treatment with benralizumab in real life

Mepolizumab Improves and Sustains Asthma Control and Lung Function in Patients with Severe Asthma Independent of Baseline Blood Eosinophil Count in the Real World: Results from REALITI-A at 2 Years

Monitoring for early warning signs of asthma attacks and response to treatment with oral corticosteroids using the Albus Home contactless monitoring system

New strategies in the treatment of severe asthma

Next-Generation cellular therapy: should CAR-T cells be considered for allergy and asthma treatment

Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years

Registry on Severe Asthma with and without biological treatment in Spain: Results of a 2 year follow-up of AlergoDATA

Self-reported treatment preferences of patients switching from prior prophylactic therapies to donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 OASISplus study

Serum cytokine profiles of pediatric normal weight asthma and overweight/obese asthma and their correlation with pulmonary function indices

Severe asthma and sleep disorders: a Severe Asthma Network Italy (SANI) analysis

Successful treatment of severe asthma after switch of biologics. A case report

Sustained reduction in Severe Asthma Exacerbations and Hospitalisations in the 12 months after Alpine Altitude Climate Treatment

Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml

Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy

The Use of Long-acting Muscarinic Antagonist (LAMA) in the Treatment of Asthma: A Tertiary Asthma Center Experience

The effect of tezepelumab treatment on the incidence of asthma exacerbations co-occurring with acute respiratory illnesses attributed to infections: results from a pooled analysis of the PATHWAY and NAVIGATOR studies

The relationship between asthma duration and biomarker profiles in severe asthma

The treatment of eosinophilic asthma with mepolizumab and benralizumab: relative effectiveness

Toward Optimal disease control: impact of maintenance inhaler therapy and device transition in severe asthma patients undergoing monoclonal antibody treatment

Treatment of different asthma endotypes

Treatment of severe asthma (update)

Treatment with Barzolvolimab Leads to Sustained Improvement in Angioedema in Chronic Spontaneous Urticaria (CSU) patients: Results from 52 Weeks of Treatment

Worse asthma control in patients with asthma and respiratory allergies in the CAPTURE study: Rationale for developing the RespiratoryAllergyOptimiser

Asthma control, lung function, and quality of life in pediatric patients with severe asthma undergoing biological treatment

Characteristics and Asthma Control Status of Severe Asthma Patients in the Korean Severe Asthma Registry-2 (KoSAR-2)

Characteristics of asthma phenotypes: Does coexistence of allergic and eosinophilic asthma increase asthma severity?

Decoding Asthma Therapies: Transcriptomic differences between benralizumab and mepolizumab treatment in patients with severe eosinophilic asthma

Inhaled Corticosteroid Reduction Effects on Asthma Outcomes after Three Years of Benralizumab Treatment in Severe Asthma Patients

Investigation Of Treatment Responses And Clinical Characteristics Of Patients With The Late-Onset Asthma Phenotype Under Biological Treatment

Patients with severe eosinophilic asthma starting anti-IL5 treatment after 2018 have better preserved lung function compared to the patients who started treatment earlier

Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website